Tuesday, September 29, 2020
Regeneron says its Covid-19 treatment reduces viral levels, improves symptoms
REGN-COV2 is part of a class of biotech therapies known as monoclonal antibodies. Several companies are using the technology to manufacture copies of human antibodies to the new coronavirus.from Hindustan Times - world https://ift.tt/2SewKXG
via IFTTT
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment